NASDAQ:KPRX

Kiora Pharmaceuticals Stock Forecast

etoro logo Buy KPRX
*Your capital is at risk
$2.46
-0.0500 (-1.99%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of KPRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KPRX to Watchlist?
Some Reasons Why To Add KPRX:
  • Lower volatility than the market (beta -0.39)
  • Highly efficient cash conversion (101% FCF/OCF ratio)
  • Trading above its 200-day moving average
PDF

Weaker technical forecast for Kiora Pharmaceuticals, Inc. as stock downgraded to Hold/Accumulate
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 10, 2026 Loss -1.99%

The Kiora Pharmaceuticals, Inc. stock price fell by -1.99% on the last day (Monday, 13th Jul 2026) from $2.51 to $2.46. During the last trading day the stock fluctuated 5.73% from a day low at $2.43 to a day high of $2.57. The price has fallen in 4 of the last 10 days and is down by -3.15% for this period. Volume has increased on the last day by 13 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 17 thousand shares were bought and sold for approximately $41.63 thousand.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $2.51. A reaction back to this level may hold a second chance to get out before further falls.

KPRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 15, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kiora Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.54 and $2.60. A break-up above any of these levels will issue buy signals. Kiora Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Kiora Pharmaceuticals, Inc. stock

Kiora Pharmaceuticals, Inc. finds support from accumulated volume at $2.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.139 (5.73%) between high and low. For the last week, the stock has had daily average volatility of 3.04%.

Our recommended stop-loss: $2.34 (-5.02%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 18 days ago.)

Trading Expectations (KPRX) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Kiora Pharmaceuticals, Inc. to open at $2.49, and during the day (based on 14 day Average True Range), to move between $2.41 and $2.51, which gives a possible trading interval of +/-$0.107 (+/-4.43%) up or down from last closing price. If Kiora Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 4.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.45 (0.41%) than the resistance at $2.54 (3.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kiora Pharmaceuticals, Inc. stock A Buy?

Kiora Pharmaceuticals, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.188 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $2.49 ( 1.07%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KPRX Performance

Trading levels for KPRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.63 6.73%
R2 2.57 4.57%
R1 2.54 3.23%
Price 2.46
S1 2.43 -1.09%
S2 2.40 -2.42%
S3 2.35 -4.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.58 4.88%
R2 2.55 3.66%
R1 2.54 3.25%
Price 2.46
S1 2.45 -0.407%
S2 2.44 -0.81%
S3 2.35 -4.47%

FAQ

What is the symbol for Kiora Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Kiora Pharmaceuticals, Inc. is KPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kiora Pharmaceuticals, Inc. Stock?
Kiora Pharmaceuticals, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Kiora Pharmaceuticals, Inc. Stock?
Kiora Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kiora Pharmaceuticals, Inc. Stock.

What's the current price of Kiora Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Kiora Pharmaceuticals, Inc. (KPRX) share was $2.46.

What is the 52-week high and low for Kiora Pharmaceuticals, Inc. Stock?
The 52-week high for Kiora Pharmaceuticals, Inc. Stock is $3.29 and the 52-week low is $1.76.

What is the market capitalization of Kiora Pharmaceuticals, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Kiora Pharmaceuticals, Inc. is 10.903M.

When is the next earnings date for Kiora Pharmaceuticals, Inc.?
The upcoming earnings date for Kiora Pharmaceuticals, Inc. is Aug 07, 2026.
Click to get the best stock tips daily for free!
ABOUT KIORA PHARMACEUTICALS, INC.
Kiora Pharmaceuticals
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE